Electrochemotherapy as an adjunct or alternative to other treatments for unresectable or in-transit melanoma-Reference-Cited by-同舟云学术

Electrochemotherapy as an adjunct or alternative to other treatments for unresectable or in-transit melanoma

Published:2009-11 Issue:11 Volume:9 Page:1611-1630
ISSN:1473-7140
Container-title:Expert Review of Anticancer Therapy
language:en
Short-container-title:Expert Review of Anticancer Therapy

Author:

Möller Mecker G,Salwa Slawomir,Soden Declan M,O’Sullivan Gerald C

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Link

http://www.tandfonline.com/doi/pdf/10.1586/era.09.129

Reference183 articles.

1. Bleyer A, Barr R, Ries LAG.Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975–2000. National Cancer Institute, MD, USA (2006).

2. Melanoma Epidemiology and Public Health

3. Bleomycin-mediated electrochemotherapy of basal cell carcinoma

4. The European approach to in-transit melanoma lesions

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Canine squamous cell carcinoma: Electrochemotherapy association with surgery and correlation with overall survival;Veterinary and Comparative Oncology;2023-03-05

2. Potential dual synergy between electrochemotherapy and sequence of immunotherapies in metastatic melanoma: A case report;Molecular and Clinical Oncology;2023-01-10

3. Electroporation in Head-and-Neck Cancer: An Innovative Approach with Immunotherapy and Nanotechnology Combination;Cancers;2022-10-31

4. Phosphatidylserine: The Unique Dual-Role Biomarker for Cancer Imaging and Therapy;Cancers;2022-05-21

5. Electrochemotherapy and Other Clinical Applications of Electroporation for the Targeted Therapy of Metastatic Melanoma;Materials;2021-07-16